Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah M Dry

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Oncotarget|March 16, 2018
Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelsKei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Sarcoma|June 19, 2023
Fibroblast Activation Protein Expression in SarcomasJacquelyn N Crane, Danielle S Graham, Christine E Mona, et al.
Cancer Letters|October 23, 2019
Patient-derived orthotopic xenograft models of sarcomaKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Cell Cycle (Georgetown, Tex.)|December 1, 2017
Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and preventionKei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Cancer Genomics & Proteomics|April 30, 2020
A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse ModelKentaro Igarashi, Kei Kawaguchi, Norio Yamamoto, et al.
Cell Cycle (Georgetown, Tex.)|May 12, 2017
Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse modelKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Physics in Medicine and Biology|June 20, 2020
Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIsYu Gao, Anusha Kalbasi, William Hsu, et al.
Cancers|September 28, 2023
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated LiposarcomaKyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2020
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue SarcomaAnusha Kalbasi, Mitchell Kamrava, Fang-I Chu, et al.
Journal of Cellular Biochemistry|June 23, 2018
Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcomaTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Oncotarget|March 16, 2018
Intra-tumor L-methionine level highly correlates with tumor size in both pancreatic cancer and melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse modelsKei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Sarcoma|June 19, 2023
Fibroblast Activation Protein Expression in SarcomasJacquelyn N Crane, Danielle S Graham, Christine E Mona, et al.
Cancer Letters|October 23, 2019
Patient-derived orthotopic xenograft models of sarcomaKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Cell Cycle (Georgetown, Tex.)|December 1, 2017
Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and preventionKei Kawaguchi, Qinghong Han, Shukuan Li, et al.
Cancer Genomics & Proteomics|April 30, 2020
A Novel Anionic-phosphate-platinum Complex Effectively Targets a Cisplatinum-resistant Osteosarcoma in a Patient-derived Orthotopic Xenograft Mouse ModelKentaro Igarashi, Kei Kawaguchi, Norio Yamamoto, et al.
Cell Cycle (Georgetown, Tex.)|May 12, 2017
Intra-arterial administration of tumor-targeting Salmonella typhimurium A1-R regresses a cisplatin-resistant relapsed osteosarcoma in a patient-derived orthotopic xenograft (PDOX) mouse modelKentaro Igarashi, Kei Kawaguchi, Takashi Murakami, et al.
Physics in Medicine and Biology|June 20, 2020
Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIsYu Gao, Anusha Kalbasi, William Hsu, et al.
Cancers|September 28, 2023
IGF2BP3 as a Prognostic Biomarker in Well-Differentiated/Dedifferentiated LiposarcomaKyle D Klingbeil, Jack Pengfei Tang, Danielle S Graham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2020
A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue SarcomaAnusha Kalbasi, Mitchell Kamrava, Fang-I Chu, et al.
Journal of Cellular Biochemistry|June 23, 2018
Tumor-targeting Salmonella typhimurium A1-R arrests a doxorubicin-resistant PDGFRA-amplified patient-derived orthotopic xenograft mouse model of pleomorphic liposarcomaTasuku Kiyuna, Yasunori Tome, Takashi Murakami, et al.
Pageof 15